Company builds on nearly 10 years of GLP-1 experience, expanding its Sustainable Weight Loss solution to deliver medication-free and medication-assisted weight loss DENVER--(BUSINESS WIRE)-- Virta Health has released first-of-its-kind, peer-reviewed data demonstrating the companys approach to personalized nutrition therapy results in sustained weight loss after the discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1s), including Ozempic
On average, patients notice a reduction in the fullness of their double chin after two sessions and greater results after four to six sessions
It prevents cravings and provides a satiating effect due to soluble fibers that trap bile salts and cholesterol in the body, thus promoting their elimination by also stimulating intestinal transit
And then we'll sometimes hear, like, oh, we did a $50,000 dollar fine for this one insurance company after, like, a decade of denials